Metraipolis › archive › dc_468a292fe3fe
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant — Europe PMC PMID:40956828
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40956828
- DOI
- 10.1371/journal.pone.0330974
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:56:21.942Z
- SHA-256 of the archived text
079bffea251ae31c6f1e4177e22254cb274b185f3c6efca222acf4875f1dfcb3- Stable URL of this page
https://metraipolis.com/documento/dc_468a292fe3fe
How to cite
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant — Europe PMC PMID:40956828 — Europe PMC (en), https://europepmc.org/article/MED/40956828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_468a292fe3fe (Metraipolis archive dc_468a292fe3fe, sha256 079bffea251ae31c6f1e4177e22254cb274b185f3c6efca222acf4875f1dfcb3)
BibTeX
@misc{dc468a292fe3fe,
title = {Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant — Europe PMC PMID:40956828},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40956828},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_468a292fe3fe; sha256 079bffea251ae31c6f1e4177e22254cb274b185f3c6efca222acf4875f1dfcb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40956828. Agents can read the archived copy with the MCP tool read_document.